The University of Southampton
University of Southampton Institutional Repository

Intravesical chemotherapy for superficial bladder cancer : an in vitro study of anthracyclines, pH and multidrug resistance

Intravesical chemotherapy for superficial bladder cancer : an in vitro study of anthracyclines, pH and multidrug resistance
Intravesical chemotherapy for superficial bladder cancer : an in vitro study of anthracyclines, pH and multidrug resistance

Trials have demonstrated a reduction in bladder cancer recurrence rates of approximately 45% following intravescial chemotherapy. Treatment failures are likely to be due, at least in part, to the development of clones of tumour cells expressing resistance to these chemotherapy agents. This study has addressed the methods available for increasing the efficacy and response rates of epirubicin and doxorubicin-based chemotherapy.

An anthracycline-sensitive bladder cancer cell line together with a multidrug resistant subline has been used in this in vitro study. Utilising the inherent fluorescence of the anthracyclines, we have quantified their rate of uptake over time, the effect of multidrug resistance reversing agents and the effect of pH changes in equivalent drug sensitive and drug resistant bladder cancer cells using flow cytometry. The intracellular distribution of these agents has been studied under similar conditions using confocal microscopy and the relevance of these findings to proposed mechanisms of MDR is discussed. Spectrofluorimetry has been used to establish the behaviour of these agents both in free solution and bound to DNA at a variety of pH levels. The conclusions have been tested using the MTT cytotoxicity assay.

In the bladder cancer cell line expressing the MDR phenotype, a significant increase in drug uptake and cytotoxicity can be demonstrated by the addition MDR reversing agents.

Alkalinisation of the anthracycline solution also independently increases drug uptake and cytotoxicity in sensitive cells as well as in resistant cells treated with MDR reversing agents, independently of the direct cytotoxicity of the alkaline medium. These affects appear to be additive.

University of Southampton
Duffy, Peter Martin
bd00d3b4-51a5-4171-8ad9-d98213d5c890
Duffy, Peter Martin
bd00d3b4-51a5-4171-8ad9-d98213d5c890

Duffy, Peter Martin (1999) Intravesical chemotherapy for superficial bladder cancer : an in vitro study of anthracyclines, pH and multidrug resistance. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Trials have demonstrated a reduction in bladder cancer recurrence rates of approximately 45% following intravescial chemotherapy. Treatment failures are likely to be due, at least in part, to the development of clones of tumour cells expressing resistance to these chemotherapy agents. This study has addressed the methods available for increasing the efficacy and response rates of epirubicin and doxorubicin-based chemotherapy.

An anthracycline-sensitive bladder cancer cell line together with a multidrug resistant subline has been used in this in vitro study. Utilising the inherent fluorescence of the anthracyclines, we have quantified their rate of uptake over time, the effect of multidrug resistance reversing agents and the effect of pH changes in equivalent drug sensitive and drug resistant bladder cancer cells using flow cytometry. The intracellular distribution of these agents has been studied under similar conditions using confocal microscopy and the relevance of these findings to proposed mechanisms of MDR is discussed. Spectrofluorimetry has been used to establish the behaviour of these agents both in free solution and bound to DNA at a variety of pH levels. The conclusions have been tested using the MTT cytotoxicity assay.

In the bladder cancer cell line expressing the MDR phenotype, a significant increase in drug uptake and cytotoxicity can be demonstrated by the addition MDR reversing agents.

Alkalinisation of the anthracycline solution also independently increases drug uptake and cytotoxicity in sensitive cells as well as in resistant cells treated with MDR reversing agents, independently of the direct cytotoxicity of the alkaline medium. These affects appear to be additive.

This record has no associated files available for download.

More information

Published date: 1999

Identifiers

Local EPrints ID: 464246
URI: http://eprints.soton.ac.uk/id/eprint/464246
PURE UUID: 5a2b8d82-6a35-46a1-bc0e-1f70e9c7b48d

Catalogue record

Date deposited: 04 Jul 2022 21:43
Last modified: 23 Jul 2022 02:06

Export record

Contributors

Author: Peter Martin Duffy

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×